Mentoring Translational Scientists in Clinical Trial Immune Monitoring
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
批准号:
10359792
负责人:
Emanual M. Maverakis
金额:
$18.77万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-01 至 2026-02-28
关键词:
AcademyAgeAge-YearsAncillary StudyAsthmaAutoimmune DiseasesAutoimmunityAwardB-LymphocytesBig Data MethodsBiological MarkersCancer PatientCellsChargeClinicalClinical InvestigatorClinical ResearchClinical TrialsCulture MediaDataData SetDevelopmentDiagnosticDiseaseDissociationDistantDoseDouble-Blind MethodEnsureEtiologyFemaleFunctional disorderFutureGalactoseGenderGeneticGlycobiologyGlycocalyxGlycoconjugatesGlycopeptidesGlycoproteinsGoalsHumanHypersensitivityIgEImmunogeneticsImmunoglobulin GImmunologic MonitoringImmunologicsImmunotherapyIndividualInflammatoryInstitutionIsomerismLaboratoriesLibrariesLipidsLiquid ChromatographyMapsMeasuresMediatingMentorsMethodologyMethodsMid-Career Clinical Scientist Award (K24)MindMonitorNational Research CouncilNucleic AcidsOralOrganismPathogenicityPatientsPatternPhase I Clinical TrialsPhysiciansPilot ProjectsPlacebo ControlPlasmaPlayPolysaccharidesProceduresProteinsProtocols documentationRandomizedResearchResearch DesignResource SharingRheumatoid ArthritisRoleSamplingScientistSerumSeverity of illnessSiteTechnologyTherapeuticTimeTrainingTranslatingUnited States National Institutes of Healthbaseclinical applicationclinically relevantcytokineexperiencefeedingglycosylationhuman diseaseimprovedinstrumentationinterestmalemonomermultiple reaction monitoringnovelpatient oriented researchphase 1 studypredicting responseprognostictechnology developmenttranslational scientisttreatment response
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Title: Mentoring Physician Scientists in Patient-Oriented Research
ABSTRACT
Dr. Maverakis is a physician-scientist trained in immunogenetics, glycobiology, and big data
analytics. His research focuses on the use of state-of-the-art methodologies to study patients with
autoimmunity and cancer patients receiving immunotherapy. His group constructs diagnostic
classifiers, as well as predictive classifiers to identify patients who will: experience a progression
in disease severity, respond to a particular therapy, or develop an associated disease. With this
goal in mind, Dr. Maverakis and his collaborator, Carlito Lebrilla, have created a site-specific map
of the human serum glycome for use in biomarker research and discovery. Dr. Maverakis is an
award-winning mentor with a strong track-record of training clinical-investigators. He is the
director of the UC Davis Immune Monitoring Shared Resource and in this capacity, is charged
with mentoring young clinical-scientists, especially with regards to clinical trial ancillary study
design. An NIH K24 Award will be integral to his future development as a successful mentor to
young clinical-investigators. It will ensure that he has protected time to teach and mentor clinical-
investigators from various backgrounds to help them obtain research independence. He presents
a plan for improving the quality and quantity of his mentoring, including extending his
mentoring activities to other academic institutions. In addition, Dr. Maverakis proposes to
augment his current patient-oriented-research by designing and conducting early stage clinical
studies to explore novel treatments and their biomechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stratedigm S100EON high-parameter flow cytometer to support multi-institutional research programs
-
批准号:10431674
-
项目类别:
-
资助金额:$59.98万
-
财政年份:2022
-
负责人:Emanual M. Maverakis
-
依托单位:
Mentoring Translational Scientists in Clinical Trial Immune Monitoring
-
批准号:10670051
-
项目类别:
-
资助金额:$18.77万
-
财政年份:2021
-
负责人:Emanual M. Maverakis
-
依托单位:
Investigation and Development of New Therapeutic Avenues for Scleroderma
-
批准号:8792820
-
项目类别:
-
资助金额:$51.03万
-
财政年份:2011
-
负责人:Emanual M. Maverakis
-
依托单位:
Investigation and Development of New Therapeutic Avenues for Scleroderma
-
批准号:8147047
-
项目类别:
-
资助金额:$230.88万
-
财政年份:2011
-
负责人:Emanual M. Maverakis
-
依托单位:
Characterization of Pathogenic T cells in Alopecia Areata
-
批准号:8213547
-
项目类别:
-
资助金额:$7.38万
-
财政年份:2010
-
负责人:Emanual M. Maverakis
-
依托单位:
Characterization of Pathogenic T cells in Alopecia Areata
-
批准号:7880365
-
项目类别:
-
资助金额:$7.65万
-
财政年份:2010
-
负责人:Emanual M. Maverakis
-
依托单位:
Characterization of Pathogenic T cells in Alopecia Areata
-
批准号:8045448
-
项目类别:
-
资助金额:$7.36万
-
财政年份:2010
-
负责人:Emanual M. Maverakis
-
依托单位:
gC399tr an inhibitor of autoimmunity
-
批准号:7476622
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2008
-
负责人:Emanual M. Maverakis
-
依托单位:
gC399tr an inhibitor of autoimmunity
-
批准号:7569013
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2008
-
负责人:Emanual M. Maverakis
-
依托单位:
gC399tr an inhibitor of autoimmunity
-
批准号:7779385
-
项目类别:
-
资助金额:$11.9万
-
财政年份:2008
-
负责人:Emanual M. Maverakis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: